HEPATITIS D
Clinical trials for HEPATITIS D explained in plain language.
Never miss a new study
Get alerted when new HEPATITIS D trials appear
Sign up with your email to follow new studies for HEPATITIS D, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New shot aims to tame tough liver virus
Disease control OngoingThis study is testing an experimental injection called Hepalatide (L47) to see if it can help control chronic hepatitis D, a serious liver infection. About 90 adult patients will receive either a low dose, a high dose, or delayed treatment for 48 weeks to measure how well the dru…
Matched conditions: HEPATITIS D
Phase: PHASE2 • Sponsor: Shanghai HEP Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New hepatitis d drug tested for preventing deadly liver complications
Disease control OngoingThis study investigates whether a new antiviral drug called Bulevirtide can reduce dangerous high pressure in the liver (portal hypertension) in people with both hepatitis B and hepatitis D infections who also have liver scarring (cirrhosis). Researchers are measuring pressure ch…
Matched conditions: HEPATITIS D
Sponsor: Hannover Medical School • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC